P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW...

por Munir, Talha, Shadman, Mazyar, Robak, Tadeusz, R. Brown, Jennifer, Kahl, Brad, Ghia, Paolo, Giannopoulos, Krzysztof, Simkovic, Martin, Österberg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Ciepluch, Hanna, Greil, Richard, Hanna, Merit, Tani, Monica, Trneny, Marek, M. Brander, Danielle, W. Flinn, Ian, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, De Guibert, Sophie, Tumyan, Gayane, Laribi, Kamel, Antonio Garcia Marco, Jose, LI, Jianyong, Tian, Tian, Ramakrishnan, Vanitha, Liu, Yu, Szeto, Andy, Paik, Jason, Cohen, Aileen, Tam, Constantine, Jurczak, Wojciech
Publicado 2023